If you were tasked with resurrecting an extinct animal, where would you even begin? Colossal Biosciences, a synthetic biology company founded in 2021 by a Harvard geneticist George Church and ...

Google Cloud's Multiomics Suite Delivers Powerful AI and Bioinformatics Tools for Biotech Companies, Pharmaceutical Firms, and Public Sector Organizations DALLAS, TX / ACCESSWIRE / May 17, 2023 / Form ...

When George Church, PhD, and co-founders established Colossal Biosciences, they envisioned applying their advancements in CRISPR gene editing to the loss of biodiversity, species preservation, and ...

As companies aim to cut costs and reel in spending amid uncertain macroeconomic conditions, Form Bio thinks it is actually the perfect time to launch its platform. The software company was developed ...

DALLAS, Texas--(BUSINESS WIRE)--Colossal Biosciences, the de-extinction company behind the woolly mammoth and thylacine, today announced the launch of Form Bio, a new independent company offering a ...

SAN FRANCISCO / ACCESSWIRE / June 27, 2024 / Form Bio, the provider of advanced computational life sciences technology and PacBio (NASDAQ:PACB), a leading developer of high-quality, highly accurate ...

Partnership leverages AI-powered genome design to optimize AAV constructs, accelerate lead candidate selection, and improve drug substance manufacturability for rare and ultra-rare neuromuscular ...

AI-powered vector design and preclinical validation mark the first step in a multi-phase program aimed at accelerating the path from discovery to clinical assessment in Alzheimer's disease. AUSTIN, TX ...

Form Bio, the breakthrough computational life sciences platform, announced that it has been selected to help organizations adopt Google Cloud's Multiomics Suite, accelerating the research of life ...

Newly Created Form Bio Raises $30M Series A Funding Led by JAZZ Venture Partners to empower life scientists with a complete platform for managing large datasets, executing verified workflows, ...